Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma

Ophthalmology

Volumn 108, Issue 10, 2001, Pages 1767-1776

  Sivak Callcott, Jennifer A ^a   O'Day, Denis M ^a   Gass, J Donald M ^a   Tsai, James C ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; MITOGENIC AGENT; VASCULOTROPIN;

ARTICLE; DIODE LASER; ELECTRORETINOGRAPHY; EVIDENCE BASED MEDICINE; FLUORESCENCE ANGIOGRAPHY; GLAUCOMA SURGERY; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; NEOVASCULAR GLAUCOMA; PRIORITY JOURNAL; TRABECULECTOMY;

ANTIMETABOLITES; EVIDENCE-BASED MEDICINE; FLUOROPHOTOMETRY; GLAUCOMA DRAINAGE IMPLANTS; GLAUCOMA, NEOVASCULAR; GONIOSCOPY; HUMANS; IRIS; LASER COAGULATION; TRABECULECTOMY;

EID: 0034816746     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(01)00775-8     Document Type: Article

References (73)

1. Neovascular glaucoma. Etiologic considerations
2. Long-term results of valve implants in filtering surgery for eyes with neovascular glaucoma
3. Evidence-based analysis of prophylactic treatment of asymptomatic retinal breaks and lattice degeneration
4. Factors controlling ocular angiogenesi
5. Rationale for therapy in neovascular glaucoma
6. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
7. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma
8. Vascular endothelial growth factor level in aqueous humor of diabetic patients with rubeotic glaucoma is markedly elevated
9. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye diseases. Studies in nondiabetic and diabetic subjects
10. Increased interleukin-6 in aqueous humor of neovascular glaucoma
11. Neovascular glaucoma and vitreous hemorrhage after cataract surgery in patients with diabetes mellitus
12. The effect of lensectomy on the incidence of iris neovascularization and neovascular glaucoma after vitrectomy for diabetic retinopathy
13. Neovascular glaucoma following neodymium-YAG laser posterior capsulotomy
14. The myofibroblastic component of rubeosis iridis
15. The association of rubeosis iridis with endothelialisation of the anterior chamber: Report of a clinical case with histopathological review of 16 additional cases
16. Clinical and infrared pupillometry in central retinal vein occlusion
17. The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion
18. Baseline and early natural history report. The Central Vein Occlusion Study
19. Diabetic iris neovascularization
20. Fundus iris fluorescein angiography: Evaluation of its use in the diagnosis of rubeosis iridis
21. Fluorescein gonioangiography in diabetic neovascularisation
22. Infrared angiography of the anterior ocular segment
23. Cone b-wave implicit time as an early predictor of rubeosis in central retinal vein occlusion
24. Electroretinogram parameters at presentation as predictors of rubeosis in central retinal vein occlusion patients
25. Early electroretinography in unilateral central retinal vein occlusion as a predictor of rubeosis iridis
26. The effect of pan-retinal photocoagulation on rubeosis iridis
27. Effects of panretinal photocoagulation on rubeosis iridis, angle neovascularization, and neovascular glaucoma
28. Regression of iris neovascularization following panretinal photocoagulation
29. Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization
30. A prospective follow-up study of panretinal photocoagulation in preventing neovascular glaucoma following ischaemic central retinal vein occlusion
31. Diabetic rubeosis and panretinal photocoagulation. A prospective, controlled, masked trial using iris fluorescein angiography
32. Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction
33. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study
34. Comparison between efficacy of full-and mild-scatter (panretinal) photocoagulation on the course of diabetic rubeosis iridis
35. The role of goniophotocoagulation in neovascularization of the anterior chamber angle
36. Oxygen therapy and intraocular oxygenation
37. Neovascular glaucoma associated with uveitis
38. Filtration surgery in the treatment of neovascular glaucoma
39. Rubeotic glaucoma
40. Diabetic iris neovascularization. Natural history and treatment
41. A prospective evaluation of anterior retinal cryoablation in neovascular glaucoma
42. Panretinal cryopexy for the management of neovascularization of the iris
43. Role of anterior retinal cryoablation in the management of neovascular glaucoma
44. Panretinal cryotherapy in neovascular disease
45. Initial clinical experience using a diode laser in the treatment of retinal vascular disease
46. Combined transscleral diode laser cyclophotocoagulation and transscleral retinal photocoagulation for refractory neovascular glaucoma
47. Peripheral transscleral retinal diode laser for rubeosis iridis
48. Peripheral transscleral retinal diode laser for rubeosis iridis
49. Transscleral ruby laser cycloco-agulation
50. Transscleral cyclophotocoagulation with the diode laser for neovascular glaucoma
51. "Cyclodiode." Transscleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma
52. Tube-shunt surgery versus neodymium:YAG cyclophotocoagulation in the management of neovascular glaucoma
53. Ophthalmic laser microendoscope ciliary process ablation in the management of neovascular glaucoma
54. High incidence of sympathetic ophthalmia after contact and noncontact neodymium:YAG cyclotherapy
55. Surgical intervention on the ciliary body. New trends for the relief of glaucoma
56. Rubeosis iridis and neovascular glaucoma. Evaluation of cyclocryotherapy
57. Cyclocryotherapy in the treatment of advanced glaucoma
58. Anterior segment ischemia after cyclocryotherapy
59. Noncontact transscleral Nd:YAG cyclophotocoagulation: A long-term follow-up of 500 patients
60. Antiglaucomatous ciliary body excision
61. 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study
62. Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up
63. Combined Molteno implantation and pars plana vitrectomy for neovascular glaucomas
64. Carbon dioxide laser trabeculostomy for the treatment of neovascular glaucoma
65. Long-term results of modified trabeculectomy with supramid implant for neovascular glaucoma
66. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion
67. Retinectomy lowers intraocular pressure in otherwise intractable glaucoma: Preliminary results
68. Glaucoma drainage devices: Pros and cons
69. The visual outcome in cases of neovascular glaucoma
70. Molteno tube implantation for neovascular glaucoma. Long-term results and factors influencing the outcome
71. Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma
72. Combined pars plana vitrectomy and glaucoma drainage implant placement for refractory glaucoma